Assessing Ventyx Biosciences (VTYX) Valuation After Sharp Share Price Momentum And A High P/B Multiple [Yahoo! Finance]
Ventyx Biosciences, Inc. (VTYX)
Company Research
Source: Yahoo! Finance
Ventyx Biosciences (VTYX) has drawn fresh attention after a strong share price move, with the stock showing a 52% gain over the past month and a very large 1 year total return. For context, the company remains a clinical stage biopharmaceutical business with no reported revenue and a net loss of US$106.607 million. Recent price action is being driven by expectations around its drug pipeline rather than current sales or earnings. Short term traders may focus on the 0.8% return over the past day and 1% move over the past week, while longer term holders are likely more interested in the 68% year to date return and the 3 year total return, which currently sits at a 66% decline. See our latest analysis for Ventyx Biosciences. Ventyx Biosciences has moved from deep losses for early investors to sharp recent strength, with strong short term share price momentum building after a very large 1 year total shareholder return. If this kind of rebound in a clinical stage name has your at
Show less
Read more
Impact Snapshot
Event Time:
VTYX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VTYX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VTYX alerts
High impacting Ventyx Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
VTYX
News
- Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ventyx Biosciences, Inc. - VTYXPR Newswire
- Halper Sadeh LLC Encourages VTYX and SNCY Shareholders to Contact the Firm to Discuss Their RightsGlobeNewswire
- Why Eli Lilly (LLY) Stock Is Down Today [Yahoo! Finance]Yahoo! Finance
- Halper Sadeh LLC Encourages VTYX, PEN, CWAN Shareholders to Contact the Firm to Discuss Their RightsGlobeNewswire
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYXPR Newswire
VTYX
Earnings
- 11/6/25 - Beat
VTYX
Sec Filings
- 1/29/26 - Form SCHEDULE
- 1/22/26 - Form PREM14A
- 1/22/26 - Form DEFA14A
- VTYX's page on the SEC website